What does this Advisor Specialize in? Find a financial advisor who specializes in the area of expertise you require. It's important to find an advisor who can help you approach your personal and ...

Neeraj Agarwal, MD, of the University of Utah's Huntsman Cancer Institute, discusses challenges to progress in getting FDA approval for PARP inhibitors in prostate cancer. FDA approvals for PARP ...

Neeraj Agarwal, MD, University of Utah Huntsman Cancer Institute, shares his experience regarding the prostate cancer patients who could potentially benefit from PARP inhibition. In your opinion, who ...

Neeraj Agarwal, MD, is now a distinguished member of the Fellows of the American Society of Clinical Oncology. This distinction recognizes his extraordinary volunteer service, engagement, and ...

San Francisco-based CRO Vial has beefed up its oncology expertise by adding cancer physician Neeraj Agarwal, M.D., to its scientific advisory board. Vial announced the appointment earlier this month, ...

Please provide your email address to receive an email when new articles are posted on . In 2017, the positive results of two trials — CheckMate-214 and CABOSUN — garnered a great deal of attention and ...

TALAPRO-2, a study led by Neeraj Agarwal, MD, FASCO, demonstrated that using TALZENNA, in combination with XTANDI, may reduce the risk of disease progression or death by 37%. Agarwal, Presidential ...

Adding talazoparib to enzalutamide led to a statistically significant and clinically meaningful improvement in overall survival in patients with metastatic castration-resistant prostate cancer ...

Neeraj Agarwal is a professor of Medicine and Director of the Genitourinary Oncology Program at the Huntsman Cancer Institute at the University of Utah in Salt Lake City, Utah. This website uses ...